320 related articles for article (PubMed ID: 22652964)
41. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
Nadal RC; Rigby SE; Viles JH
Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
[TBL] [Abstract][Full Text] [Related]
42. NMR metabolomic investigation of astrocytes interacted with Aβ₄₂ or its complexes with either copper(II) or zinc(II).
Rocchi A; Valensin D; Aldinucci C; Giani G; Barbucci R; Gaggelli E; Kozlowski H; Valensin G
J Inorg Biochem; 2012 Dec; 117():326-33. PubMed ID: 23062696
[TBL] [Abstract][Full Text] [Related]
43. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
44. Metal binding of flavonoids and their distinct inhibition mechanisms toward the oxidation activity of Cu2+-β-amyloid: not just serving as suicide antioxidants!
Tay WM; da Silva GF; Ming LJ
Inorg Chem; 2013 Jan; 52(2):679-90. PubMed ID: 23301941
[TBL] [Abstract][Full Text] [Related]
45. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
46. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
[TBL] [Abstract][Full Text] [Related]
47. Nucleoside 5'-phosphorothioate derivatives are highly effective neuroprotectants.
Danino O; Giladi N; Grossman S; Fischer B
Biochem Pharmacol; 2014 Apr; 88(3):384-92. PubMed ID: 24548458
[TBL] [Abstract][Full Text] [Related]
48. Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface.
Ryu J; Girigoswami K; Ha C; Ku SH; Park CB
Biochemistry; 2008 May; 47(19):5328-35. PubMed ID: 18422346
[TBL] [Abstract][Full Text] [Related]
49. Effect of transition metals in synaptic damage induced by amyloid beta peptide.
Uranga RM; Giusto NM; Salvador GA
Neuroscience; 2010 Oct; 170(2):381-9. PubMed ID: 20674685
[TBL] [Abstract][Full Text] [Related]
50. Influence of chelators and iron ions on the production and degradation of H2O2 by beta-amyloid-copper complexes.
Deraeve C; Pitie M; Meunier B
J Inorg Biochem; 2006 Dec; 100(12):2117-26. PubMed ID: 17011628
[TBL] [Abstract][Full Text] [Related]
51. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
Jun S; Gillespie JR; Shin BK; Saxena S
Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
[TBL] [Abstract][Full Text] [Related]
52. Oligonucleotides are potent antioxidants acting mainly as metal-ion chelators.
Fischer B; Zobel E
Nucleic Acids Symp Ser (Oxf); 2008; (52):485-6. PubMed ID: 18776465
[TBL] [Abstract][Full Text] [Related]
53. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.
Dikalov SI; Vitek MP; Mason RP
Free Radic Biol Med; 2004 Feb; 36(3):340-7. PubMed ID: 15036353
[TBL] [Abstract][Full Text] [Related]
54. Electroanalysis of the interaction between (-)-epigallocatechin-3-gallate (EGCG) and amyloid-β in the presence of copper.
Zhang B; Cheng XR; da Silva IS; Hung VW; Veloso AJ; Angnes L; Kerman K
Metallomics; 2013 Mar; 5(3):259-64. PubMed ID: 23443273
[TBL] [Abstract][Full Text] [Related]
55. Hydroxyl radical scavenging assay of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method using catalase for hydrogen peroxide degradation.
Ozyürek M; Bektaşoğlu B; Güçlü K; Apak R
Anal Chim Acta; 2008 Jun; 616(2):196-206. PubMed ID: 18482604
[TBL] [Abstract][Full Text] [Related]
56. Selective destabilization of soluble amyloid beta oligomers by divalent metal ions.
Garai K; Sengupta P; Sahoo B; Maiti S
Biochem Biophys Res Commun; 2006 Jun; 345(1):210-5. PubMed ID: 16678130
[TBL] [Abstract][Full Text] [Related]
57. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
58. Pt(II) compounds interplay with Cu(II) and Zn(II) coordination to the amyloid-β peptide has metal specific consequences on deleterious processes associated to Alzheimer's disease.
Collin F; Sasaki I; Eury H; Faller P; Hureau C
Chem Commun (Camb); 2013 Mar; 49(21):2130-2. PubMed ID: 23386213
[TBL] [Abstract][Full Text] [Related]
59. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.
Deraeve C; Boldron C; Maraval A; Mazarguil H; Gornitzka H; Vendier L; Pitié M; Meunier B
Chemistry; 2008; 14(2):682-96. PubMed ID: 17969218
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
